ArticleEuropean urology2020

Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study.

Andrea Necchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.